About Us

TICEBA is a highly innovative German bio-pharmaceutical Life-Science Company, which operates in the fields of stem cell research and regenerative medicine. As the world's first private tissue bank, the German company offers its clients the storage of skin stem cells as personal, biological life insurance and has established itself as a pharmaceutical active ingredient manufacturer for stem cell-based therapies.

TICEBA - Company - Picture 01TICEBA - Company - Picture 02


TICEBA conducts the sampling and long term storage of stem cells from the human skin based on its own research. International research findings are taken into account and the highest international standards are met.

TICEBA is the first tissue bank worldwide to offer its customers the personal and individual storage of skin tissue and the stem cells contained therein - as unique, valuable health care measure at the highest level and in accordance with the latest findings of science and technology.

Clinical Trials

We are now also recruiting patients for further clinical studies in phase I/IIa with allogeneic ABCB5-positive (ABCB5+) mesenchymal stem cells for the following indications: chronic venous ulcers (CVU), diabetic foot ulcers (DFU) and peripheral arterial occlusive disease (PAOD). For more information click HERE.


Besides the authorization to manufacture a human medicinal product in accordance with § 13 (1) of the German Medicinal Products Act (AMG) for autologous mesenchymal stem cells, TICEBA is also authorized to manufacture a medicinal product for allogeneic mesenchymal as well as allogeneic limbal ABCB5 + stem cells following a recent extension. For more information click HERE.

The Story of Stem Cells

Review our category "The Story of Stem Cells" with the newest topic "Stem cells in wound healing" HERE.